SARAJEVO (Bosnia and Herzegovina), September 16 (SeeNews) – Bosnian pharmaceuticals producer Bosnalijek [SAJ:BSNLR] said on Monday its net profit shrank to 437,005 marka ($246,746/223,437 euro) in the first six months of 2019, from 942,964 marka a year earlier.
First-half operating income decreased 26.5% to 46.6 million marka, while operating costs fell 14.8% to 46.8 million marka, Bosnalijek said in a filing with the Sarajevo Stock Exchange (SASE).
The company's assets totalled 294.2 million marka at the end of June, compared to 308.5 million marka at the end of 2018.
In October 2016, the government of Bosnia's Federation entity sold its 19.3% stake in Bosnalijek for 23.4 million marka to Malta-based financial services provider KBC Euro Credit Capital.
The Federation is one of the two autonomous entities that make up Bosnia and Herzegovina. The other one is the Serb Republic.
(1 euro = 1.95583 marka)